MedPath

Effectiveness of a Postal Intervention to Improve the Use of PPI

Not Applicable
Completed
Conditions
Drug Overdose
Interventions
Other: Letter by post to patients
Registration Number
NCT03840018
Lead Sponsor
Osakidetza
Brief Summary

It was a randomised intervention study, with before-and-after outcome measures and a control group, in patients who had an active long-term prescription for PPIs at high doses for at least 6 months.

Detailed Description

The intervention consisted of sending patients an informative letter by post, in which their doctor invited them to seek an appointment for a medication review. Control group patients did not receive such a letter, and they were treated as usual (their doctors received a list of identifiers of patients on high doses).

The main outcome variable was the number of active prescriptions of each PPI dose (high dose/standard dose/treatment cessation) at 6 months after the intervention.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
401
Inclusion Criteria
  • Patients under the care of our organisation who in May 2017 had an active long-term prescription for PPIs at high doses for at least 6 months.
Exclusion Criteria
  • Patients whose GPs declined to participate

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Letter by post to patientsLetter by post to patientsPatients were sent a letter explaining the risks of using PPIs at long-term high doses and encouraging them to visit their doctor
Primary Outcome Measures
NameTimeMethod
Active prescriptions of each proton pump inhibitors dose after the intervention6 months

Number of active prescriptions of each proton pump inhibitors dose (high dose/standard dose/treatment cessation) at 6 months after the intervention

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Bidasoa Integrated Health Organization

🇪🇸

Hondarribia, Gipuzkoa, Spain

© Copyright 2025. All Rights Reserved by MedPath